Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0101

A Phase II Study of Gemcitabine Plus Irinotecan (CPT-11) In Patients With Esophageal Cancer.

Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2001
Closed
02-01-2003
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
56%
Published
SWOG Clinical Trial Number
S0031

Evaluation of ZD 1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II

Research Committee(s)
Genitourinary Cancer
Activated
02-15-2001
Closed
10-15-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9915

A Phase II Study of PN401, 5-FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach.

Research Committee(s)
Gastrointestinal Cancer
Activated
02-15-2001
Closed
09-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0007
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
S0004
Closed
Phase
Accrual
36%
Published
SWOG Clinical Trial Number
S0013
Closed
Phase
Accrual
90%
Published
SWOG Clinical Trial Number
S0008
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9923

A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.

Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
08-01-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9924

A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.

Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
06-01-2001
Closed
Phase
Accrual
53%
Published
Closed
Phase
Accrual
97%
Published
Closed
Phase
Accrual
53%
Published
Closed
Phase
Accrual
99%
Published
SWOG Clinical Trial Number
S9914